MENU
Advertisement
Show Filters
Refine by Content Type
Refine by Year
Sort By:
Choose Sites to Search:
European Perspective of Percutaneous Mitral Leaflet Repair
An overview of the EVEREST trials and the MitraClip system used to treat mitral regurgitation.
By Olaf Franzen, MD; Sven Meyer, MD; Stephan Baldus, MD; Anjelika Costard-Jäckle, MD; and Thomas Meinertz, MD
Transcatheter Valve Therapies
By Ted E. Feldman, MD, FSCAI - Chief Medical Editor
CTA Case Studies
Clinical utility of cardiac CTA in patients with previous CABG.
By Jason T. Bradley, MD; Mitchell N. Rashid, MD; and Matthew W. Watkins, MD, FACC
Sponsored by Stryker Peripheral Vascular
The PERSEVERE Trial: Advancing Evidence in High-Risk PE
Global Principal Investigators discuss the design and impact of a randomized trial evaluating the FlowTriever System versus standard of care for high-risk pulmonary embolism.
With Stavros V. Konstantinides, MD, PhD, and Nicolas Meneveau, MD, PhD
Contemporary Mitral TEER and Expanding Indications
Expanding beyond the green zone.
By Nidhish Tiwari, MD; Muhammad Asim Shabbir, MD; and Nidhi Madan, MD, MPH
Contemporary Trends in Diagnosis and Management of Pulmonary Embolism
A review of the identification and classification of acute pulmonary embolic disease and modern management strategies.
By Daniel Heikali, MD, and Suhail Dohad, MD
FRAME-AMI Trial Compares FFR and Angiography to Select Non–Infarct-Related Artery Lesions for PCI in Patients With AMI and Multivessel Disease
August 28, 2022—Findings from the FRAME-AMI study found that selection of non–infarct-related artery (non-IRA) lesions for percutaneous coronary intervention (PCI) using fractional flow reserve (FFR) is superior to routine angiography-based selection in patients with acute myocardial infarction (AMI) and multivessel disease, announced the European Society of Cardiology.
PFO as Seen From the Brain
A neurological view of patent foramen ovale and closure.
By Lars Thomassen, MD, PHD, and Ulrike Waje-Andreassen, MD, PHD
Greater Benefit Seen With Multiple Arterial CABG Versus PCI in Long Term
September 25, 2015—Findings from a study that sought to investigate longer-term outcomes including the potential added advantage of multiarterial coronary artery bypass graft (MA-CABG) compared with percutaneous coronary intervention (PCI) were published by Robert H. Habib, PhD, et al in the Journal of the American College of Cardiology (2015;66:1417–1427).
Mechanisms of Transcatheter Valve Degeneration
A translational perspective.
By Hacina Gill, BSc; David Meier, MD; Althea Lai, BSc; Geoffrey W. Payne, MSc, PhD; and Stephanie L. Sellers, MSc, PhD
CoreValve: Assessing the Clinical Trials
A review of trial patient selection and results, as well as clinical implications.
By Steven J. Yakubov, MD, FACC, and Kyle Feldmann, MD
Considerations for ASD Closure
Understanding the devices and proper anatomic evaluation to prevent and manage possible complications.
By Paul Poommipanit, MD, FSCAI, FACC, and Zahid Amin, MD, FSCAI, FAAP, FACC, FAHA
Utility of ACC/AHA Lesion Classification Studied as Predictor of PCI Outcomes
November 20, 2017—In a study that was published online in Catheterization and Cardiovascular Interventions, James Theuerle, MBBS, et al investigated correlations between the American College of Cardiology/American Heart Association (ACC/AHA) coronary lesion classification and the clinical outcomes seen in contemporary percutaneous coronary intervention (PCI).
TATORT-NSTEMI Trial Shows Thrombus Aspiration Does Not Improve 12-month Outcomes
November 19, 2015— The European Society of Cardiology announced the publication of findings from the TATORT-NSTEMI trial showing that thrombus aspiration before percutaneous coronary intervention (PCI) does not improve 12-month clinical outcomes in patients with non-ST-elevation myocardial infarction (NSTEMI).
Postmarket JUPITER Registry Evaluates Second-Generation JenaValve to Treat Aortic Regurgitation
December 8, 2017—One-year outcomes from the postmarket JUPITER registry evaluating the safety and efficacy of transapical aortic valve implantation using the second-generation JenaValve transcatheter heart valve (JenaValve Technology GmbH) for aortic regurgitation were published by Miriam Silaschi, MD, et al online ahead of print in Catheterization and Cardiovascular Interventions (CCI).
Appraising the Role of PFO Closure
A review of updated trial data, available devices, and application of patent foramen ovale closure.
By Krishna S. Kallakuri, MD, and Rajeev L. Narayan, MD
The Transapical Route for TAVR
Recent data regarding transapical access for transcatheter aortic valve replacement, as well as the devices used in this procedure.
By Rafal Dworakowski, MD, PhD, and Olaf Wendler, MD, PhD, FRCS
Sponsored by CeloNova BioSciences, Inc.
Clinical Decision-Making for PCI Patients During the COVID-19 Pandemic
With Aloke Finn, MD; Rajiv Jauhar, MD, FACC, FSCAI; and S. Jay Mathews, MD, MS, FACC
Medtronic's Micra Transcatheter Pacing System Meets Safety and Effectiveness Endpoints in Global Trial
November 9, 2015—Medtronic plc announced the publication of data demonstrating that the company’s Micra transcatheter pacing system (TPS) was successfully implanted in 99.2% of patients in the trial and met its safety and effectiveness endpoints with wide margins.
Transcatheter Mitral Valve Replacement: Current Challenges and Future Perspective
Is transcatheter mitral valve replacement a better solution for mitral regurgitation than transcatheter repair techniques?
By Pavel Overtchouk, MD; Juan F. Granada, MD; and Thomas Modine, MD, PhD, MBA
